Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Start Date

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Jan 19, 2024 11:42am

121 Views

Post# 35835993

RE:RE:RE:RE:RE:Start Date

Since you are deflecting from the fact that you come here to manipulate, I'll let you in on my strategy: Loaded up in the 40s, got capital back on the run up above a buck, now free shares. Holding those free shares haha. Let's see low 80s again and buy some more. The days of sub 50 are over. Too bad you didn't load up

tell me how much time you waste manipulating, I mean attempting to, while making peasant level trades?

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets